Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 58.12%
March 31, 2026 56.35%
December 31, 2025 54.36%
September 30, 2025 49.53%
June 30, 2025 59.79%
March 31, 2025 62.04%
December 31, 2024 60.81%
September 30, 2024 56.28%
June 30, 2024 55.74%
March 31, 2024 56.40%
December 31, 2023 55.03%
September 30, 2023 55.99%
June 30, 2023 55.13%
March 31, 2023 54.62%
December 31, 2022 55.56%
September 30, 2022 54.21%
June 30, 2022 55.16%
March 31, 2022 54.02%
December 31, 2021 55.09%
September 30, 2021 55.35%
June 30, 2021 55.70%
March 31, 2021 54.21%
December 31, 2020 53.76%
September 30, 2020 52.11%
June 30, 2020 48.97%
Date Value
March 31, 2020 52.89%
December 31, 2019 58.81%
September 30, 2019 58.28%
June 30, 2019 57.39%
March 31, 2019 56.35%
December 31, 2018 57.40%
September 30, 2018 56.59%
June 30, 2018 56.94%
March 31, 2018 56.58%
December 31, 2017 55.01%
September 30, 2017 55.25%
June 30, 2017 55.54%
March 31, 2017 53.15%
December 31, 2016 54.08%
September 30, 2016 53.56%
June 30, 2016 54.84%
March 31, 2016 53.57%
December 31, 2015 53.97%
September 30, 2015 51.86%
June 30, 2015 52.04%
March 31, 2015 51.93%
December 31, 2014 50.59%
September 30, 2014 51.23%
June 30, 2014 51.79%
March 31, 2014 50.08%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 65.92%
Penumbra, Inc. 66.50%
Becton, Dickinson & Co. 46.46%
Boston Scientific Corp. 66.50%
DexCom, Inc. 63.44%

Gross Profit Margin (Quarterly) Related Metrics